Civic Intelligence

Bairex Corp

EIN 88-3515603 • 501(c)3 • San Mateo, CA

NTEE B90

Profile

Patient advocacy and health education for underprivileged populations.

5 Turtle Bay PlSan Mateo, CA 94402

www.bairex.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

NTEE B90 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

61st percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

NTEE B90 • <$500k nonprofits • Source year 2024

Net Margin

96th percentile

94%

Higher net margin than 96% of similar nonprofits.

NTEE B90 • <$500k nonprofits • Source year 2024

Top Officer Pay

79th percentile

$0

Higher top officer pay than 79% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

NTEE B90 • <$500k nonprofits • Source year 2024

Asset Growth

63rd percentile

17%

Faster asset growth than 63% of similar nonprofits.

NTEE B90 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

8th percentile

-85%

Faster revenue growth than 8% of similar nonprofits.

NTEE B90 • <$500k nonprofits • Annualized from 2023 to 2024

Assets

Up

$19,791

Up $2,847 (+17%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Up

$19,791

Up $2,847 (+17%) from 2023

Revenue

Down

$3,002

Down $16,998 (-85%) from 2023

Expenses

Down

$195

Down $2,861 (-94%) from 2023

Net Income

Down

$2,807

Down $14,137 (-83%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$20K$15K$10K$5.0K$0Assets 2023: $16,944Liabilities 2023: $0Net Assets 2023: $16,9442023Assets 2024: $19,791Liabilities 2024: $0Net Assets 2024: $19,7912024

Highlighted filing

2024

Assets$19,791
Liabilities$0
Net Assets$19,791

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$20K$15K$10K$5.0K$0Revenue 2023: $20,000Expenses 2023: $3,056Net Income 2023: $16,9442023Revenue 2024: $3,002Expenses 2024: $195Net Income 2024: $2,8072024

Highlighted filing

2024

Revenue$3,002
Expenses$195
Net Income$2,807

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
May 14, 2025
Return Version
2024v5.0
Gross Receipts
$3,002
Mission and Program Overview

Mission

Patient advocacy and health education for underprivileged populations.

Program Services

DescriptionGrantsExpenses
In-person community education sessions on cancer (primarily breast and colon cancer) were held in Tigrinya and facilitated by partnering community medical experts in Washington, D.C.; Bairex served approximately 5000 participants.$0$0
Patient advocacy/consulting services were conducted, servicing 180-200 patients and caregivers nationwide.$0$0
Online resources were made available for pre-registered programs, servicing 3000 people nationwide.$0$0
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Menghisteab BairuPresident-$0--
John HautmanChief Legal Officer-$0--
Adiam TsegaiTreasurer-$0--
Wintana BairuExecutive Director & Secretary-$0--
Filing and Contact Details

Filer

Filer Name
Bairex Corp
EIN
88-3515603
Phone
6502780776
Address
5 Turtle Bay Pl, San Mateo, CA 94402

Signing Officer

Name
Wintana Bairu
Title
Executive Director
Phone
6507731879
Signed
2025-05-14
Supplemental Narrative

Additional Explanations

Form 990-EZ, Part I, Line 4

Investment income listed is from the Bairex Corp bank checking account.

Form 990-EZ, Part III, Line (28-31)

In 2023, the Board of Directors of Bairex Corp. approved the expansion of the corporation's Mission Statement to include the complementary mission of facilitating the manufacturing and distribution, primarily in developing countries, of affordable prescription medicines, including but not limited to monoclonal antibodies. Set out below is the complete expanded Mission Statement: The mission, duty and purpose of the Corporation is to provide online courses, webinars, seminars, lectures, workshops and conferences to assist patients, caregivers, and clinicians in making up-to-date, appropriate medical treatment decisions for patients, and equipping regulators/clinical trialists with the latest study design methodologies and trial execution strategies and to facilitate the manufacturing and distribution, primarily in developing countries of affordable prescription medicines, including but not limited to monoclonal antibodies.

Raw XML Appendix181 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BenefitsPaidToOrForMembersAmt00
IRS990EZ/BooksInCareOfDetail/PersonNm0Wintana Bairu
IRS990EZ/BooksInCareOfDetail/PhoneNum06507731879
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt05 Turtle Bay Pl
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0San Mateo
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd094402
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt016984
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt019791
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt03000
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt02807
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt00
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form1120PolFiledInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt016984
IRS990EZ/Form990TotalAssetsGrp/EOYAmt019791
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GainOrLossFromSaleOfAssetsAmt00
IRS990EZ/GamingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt00
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt03002
IRS990EZ/GrossSalesOfInventoryAmt00
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt02
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MembershipDuesAmt00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt016984
IRS990EZ/NetAssetsOrFundBalancesEOYAmt019791
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt016984
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt019791
IRS990EZ/OccupancyRentUtltsAndMaintAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt04
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt33
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Menghisteab Bairu
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1John Hautman
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Adiam Tsegai
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Wintana Bairu
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Chief Legal Officer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Executive Director & Secretary
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherAssetsTotalDetail/EOYAmt00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt00
IRS990EZ/OtherRevenueTotalAmt00
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0Patient advocacy and health education for underprivileged populations.
IRS990EZ/PrintingPublicationsPostageAmt0195
IRS990EZ/ProgramServiceRevenueAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0In-person community education sessions on cancer (primarily breast and colon cancer) were held in Tigrinya and facilitated by partnering community medical experts in Washington, D.C.; Bairex served approximately 5000 participants.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1Patient advocacy/consulting services were conducted, servicing 180-200 patients and caregivers nationwide.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt2Online resources were made available for pre-registered programs, servicing 3000 people nationwide.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt20
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt20
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt00
IRS990EZ/SaleOfAssetsGrossAmt00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SpecialEventsNetIncomeLossAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt0195
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt03002
IRS990EZ/TransactionWithControlEntInd00
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0https://www.bairex.org/
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0Schedule A, Part II, Line 10 - Bairex did not receive additional income.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0Schedule A, Part II, Line 10
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt03000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt020000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt023000
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt00
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt023000
IRS990ScheduleA/SubstantialContributorsTotAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt03000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt020000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt023000
IRS990ScheduleA/TotalSupportAmt023000
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Investment income listed is from the Bairex Corp bank checking account.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1In 2023, the Board of Directors of Bairex Corp. approved the expansion of the corporation's Mission Statement to include the complementary mission of facilitating the manufacturing and distribution, primarily in developing countries, of affordable prescription medicines, including but not limited to monoclonal antibodies. Set out below is the complete expanded Mission Statement: The mission, duty and purpose of the Corporation is to provide online courses, webinars, seminars, lectures, workshops and conferences to assist patients, caregivers, and clinicians in making up-to-date, appropriate medical treatment decisions for patients, and equipping regulators/clinical trialists with the latest study design methodologies and trial execution strategies and to facilitate the manufacturing and distribution, primarily in developing countries of affordable prescription medicines, including but not limited to monoclonal antibodies.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990-EZ, Part I, Line 4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990-EZ, Part III, Line (28-31)
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Wintana Bairu
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Executive Director
ReturnHeader/BusinessOfficerGrp/PhoneNum06507731879
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-14
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0BAIREX CORP
ReturnHeader/Filer/BusinessNameControlTxt0BAIR
ReturnHeader/Filer/EIN0883515603
ReturnHeader/Filer/PhoneNum06502780776
ReturnHeader/Filer/USAddress/AddressLine1Txt05 Turtle Bay Pl
ReturnHeader/Filer/USAddress/CityNm0San Mateo
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd094402
ReturnHeader/IRSResponsiblePrtyInfoCurrInd01
ReturnHeader/ReturnTs02025-05-15T12:38:09-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.